发明名称 Angiotensin iv and analogs as regulators of fibrinolysis
摘要 Angiotensin IV (VAL-TYR-ILE-HIS-PRO-PHE), a degradation product of angiotensin II previously thought to be inactive, interacts directly with endothelial cells to induce expression of PAI-1 and thereby to inhibit clot lysis attributable to endogenous t-PA. Moreover, angiotensin IV does not effect substantial physiological changes (vasoconstriction, increased blood pressure, etc.) characteristic of angiotensin II. Fibrinolysis is promoted by reducing the amount or the effect of angiotensin IV. Fibrinolysis is inhibited by providing enhanced angiotensin IV. Methods of screening candidates for antagonizing angiotensin IV are also disclosed.
申请公布号 AU6861796(A) 申请公布日期 1997.05.22
申请号 AU19960068617 申请日期 1996.08.27
申请人 BRIGHAM & WOMEN'S HOSPITAL;WASHINGTON STATE UNIVERSITY RESEARCH FOUNDATION 发明人 DOUGLAS E. VAUGHAN;JOSEPH W HARDING
分类号 A61K38/00;A61K38/08;A61K38/55;C07K5/083;C07K5/097;C07K7/14;C07K16/26 主分类号 A61K38/00
代理机构 代理人
主权项
地址